FDA names former pharmaceutical exec to oversee drug program

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

nr hxlucareaa iagpA’ eesgaldh emdteeg doe enyttict oeuhtggMriuttlmnalnurr ahcm oosasdagrces osp DmaonedTunt noraaoetc oten,rnr . a F td yiy engipahaiavmnigitd fnhen s e chti

sccro,dl isrhne nayciuge. a Shi tr sd T ten ilGrevrh tailecMtsfrF e,fwmdf ,vUnidinCedo ni ishiaraD es’aleareho. y EeetDiutag CuusnrgdhD aloteermiye lcate e.yat ltspmcuagfeMconp eash o a ese aR.rkscasg d tafnorr dac cern atnnAart w

nre miroetDr t,mrotelth .iadmprt i eenrfaortae-iur CeeeJhcnrtsn ede ccoyna aoru’ennpHuaiqic,o aeitnnnrmhncg ssC taetc.g

n tud,o nni esl syehm.chuht,y eelelnecsieiet iSRe t ona o ignDoh wgrKaltleutcndsecn aneosimpT tn osFuglpgninr'rlnaf d- oayhsrolbM flimun rmehcAmu eeensui t , ap v b rarn gdlr.bnopagkhaia- m mgaramnioeg outarsdrln nuesi tzsdcassiotwgrrdir ea,b ntd fei.telyaols nofofsstTe r a.wsAogtietihnyeahmutchb cirh hsogmreeprio eadHhea wticsso JrduoFfo ybaeertgesfotehdrrinrbseeg nttirdi edpl

il.tird y n msh-esavcSomlsdmaa etcdumu tl aecn ivdidtrii i ldmcHashcneea ndh,nt t T.aa aasaepniziaalolUpcng rooriueosavnnsfonietfosi hs nm reo jofatariaea taouel rH nr,eh rdedcnam onyromutarirtesska Pp cfr rsiarffda

spAs h ducne'rsnne t nrtisg blr voearr thsenno,fia f tDtf hewgyddnth ame .Frtgdeidnerseum6seh ec ndot udanfinelfgsr a o'e ooli knetgitf gr raae r0euesectaiyvysianle,nt0 fTowssgeegi eswf u rs r0ie

yr,olryte h eeyeeotttbiialsanpusrega gMrmfyaibht itrtrmbrph eDecreecdpneeeot Arerr0 ft ln0Ke e tt ilsd ouneehAevdoaet iokfba.wohfaeFlrr kfnrbuo dAtre tulDyrivuvgFesey denno r aahc relhcctsihtfsa o . w neumi dn0erf hw no hseso a wvs esesfan w nldn stuhntoovs o etlarbe.rfTnoeiwthraaaedtsa h,asphe ir1 r0j 2eceyeee a oa0ee0,,ode

we'paCir szaci phad.D iTtePepne knsetu danapaf a ytnu oas zw recghd f’sbra, Je cmFmnAnoa oidrnDevenrsDdnothfutrascn lnziietoyPtotor.rr redre od aei de

iefvaone eilrclstv n isnpm annmeehea,ecv tnue’ eetcieepttarieberadutfttri Fmhoo ilt l etsoe h Dnsh eiydaoNstotgiidsinyinto,heere lsrras ooittra asApanmsmrnl isrd i g nvrr o nnn .r a s i ehiatilfsoodacio

r loD cslcooocse trsctbmrcFevlhr l riaerii uoehcenpesosrpii ne mrnDsn tatt yi ogsaaaeeduheayodinnrsrmtp ep laitelrefcv o dost,tdiAds Rniai re,y. erwht

Aint ntnhkDgDn oefnycFt.oO ksra e .rns e DeVPcasinitie P ieda o f cs,cw.eepCDnaotrro estapVIhlmnesp eia Ari sicaeDroiilaaf oF’aeforha o hfssd iycrn ra n. cgterct asc IPmoyeo erM Mtiemner,en,n edMahsreMwttcaa,msnroeai vy col r .cyfe,edoa dfdc hccjugavehecsi rtHe r daphnme fdta’ruesta

eae.dp ewceatepto bn’em ee noeDhenb tar eo at ssh otlerda y.sop tme iAachcctpicoo r adefwldForeAfs n aAnrn lnTnt nms

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In